author-photo

Anton Leighton

Hoffmann-La Roche

6

Papers

875

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

2001 Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (259)
Previous Phase II Studies In Severe Sepsis/Septic Shock Have Been Too Small To Constitute Adequate Basis For Phase III: 35

1997 Shock
Show All
- Source
- Cite
- Save
Citations (0)
p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

1997 JAMA
Show All
- Source
- Cite
- Save
Citations (239)
The influence of the microbiological findings on the response to treatment with p55-tumor necrosis factor fusion protein in patients with severe sepsis and early septic shock

1997
Show All
- Source
- Cite
- Save
Citations (0)